Table 2 Graft type and healing rate per treatment
Authors | n | BD Mean (cm) | Treatment type | Donor area/associated technique (n cases per treatment) | Primary union | Secondary union |
|---|---|---|---|---|---|---|
| Â | Nonvascularized bone graft | Â | ||||
Ring et al. [16] | 15 | 3 [2–6] | ICBG | ICBG (15) | 93 % | 93 % |
Pelissier et al. [15] | 16 | 4.3 [nr] | ICBG | ICBG (16) | 75Â % | 81Â % |
Jones et al. [27] | 15 | 4 [2.5–7] | ICBG | ICBG (15) | 67 % | 93 % |
Ryzewicz et al. [31] | 18 | 3.8 [2–6] | ICBG | ICBG (18) | 89 % | 94 % |
Niu et al. [46] | 22 | tn [tn] | ICBG | ICBG (22) | 95Â % | 100Â % |
Gulan et al. [43] | 10 | 4 [2–7] | ICBG | ICBG (10) | 100 % | 100 % |
Ring et al. [24] | 35 | 2.2 [1–6] | Multiple DS | ICBG (33)/Ulna (4) | 100 % | 100 % |
El-Sayed et al. [28] | 12 | 7 [6–10] | Multiple DS | ICBG (8)/Fibula (12) | 92 % | 92 % |
Niu et al. [41] | 19 | nr [nr] | Multiple DS | ICBG (19)/Fibula (2) | 95Â % | 95Â % |
Ristiniemi et al. [29] | 23 | 5.2 [3.5–10] | ICBG + biomembrane | ICBG (23)/biomembrane (23) | 61 % | 96 % |
Allende et al. [32] | 10 | 3.2 [1–7] | ICBG + biomembrane | ICBG (10)/biomembrane (10) | 100 % | 100 % |
Apard et al. [36] | 12 | 8.7 [6–15] | ICBG + biomembrane | ICBG (12)/TCF (4)/biomembrane (12) | 92 % | 92 % |
McCall et al. [34] | 21 | 6.6 [2–14.5] | RIA + biomembrane | RIA (21)/biomembrane (18) | 48 % | 81 % |
| Â | Vascularized bone graft | Â | ||||
Heitmann et al. [19] | 12 | 9.2 [8–12] | Free one DS | Fibula (12) | 75 % | 92 % |
Lee et al. [22] | 51 | 10.5 [4.5–17] | Free one DS | Fibula (51) | 92 % | 98 % |
Adani et al. [23] | 11 | 8.7 [6–13] | Free one DS | Fibula (11) | 73 % | 82 % |
Safoury [26] | 18 | nr [nr] | Free one DS | Fibula (18) | 94Â % | 100Â % |
Adani et al. [30] | 13 | 10.5 [6–16] | Free one DS | Fibula (13) | 69 % | 92 % |
El-Gammal et al. [48] | 13 | 12.6 [nr] | Free one DS | Fibula (13) | nr | 100Â % |
Sun et al. [35] | 10 | 9.5 [6–17] | Free one DS | Fibula (10) | 90 % | 100 % |
Zhen et al. [37] | 28 | nr [9–17] | Free one DS | Fibula (28) | 100 % | 100 % |
Chai et al. [38] | 16 | 13.8 [5–20] | Free one DS | Fibula (16) | 100 % | 100 % |
Liang et al. [44] | 14 | 6.9 [5–9] | Free one DS | Fibula (14) | 100 % | 100 % |
Liang et al. [42] | 16 | 16.4 [14–20] | Free one DS | Fibula (16) | 94 % | 100 % |
Gao et al. [45] | 18 | 9.2 [7–14] | Free one DS | Fibula (18) | 100 % | 100 % |
Özaksar et al. [47] | 21 | 10 [6–18] | Free one DS | Fibula (21) | 81 % | 95 % |
Toh et al. [18] | 19 | 4.9 [1–11] | Pedicle one DS | Fibula (19) | 95 % | 100 % |
Chung et al. [40] | 10 | 5.4 [4–8] | Pedicle one DS | Fibula (10) | 100 % | 100 % |
Yajima et al. [21] | 20 | 9.6 [3–24] | Free + pedicle one DS | Free fibula (16)/pedicle fibula (4) | 85 % | 90 % |
Georgescu et al. [39] | 44 | 8.2 [4–14] | Free one DS | Free rib (44) | 98 % | 98 % |
Pelissier et al. [15] | 24 | 9.8 [nr] | Free multiple DS | Fibula (12)/iliac (10)/arm (2) | 88Â % | 88Â % |
Yazar et al. [25] | 62 | 11.7 [6–18] | Free multiple DS | Fibula (50)/iliac (6)/rib (6) | 87 % | 95 % |
Cavadas et al. [33] | 41 | nr [4–17] | Free multiple DS + biomembrane | Fibula (38)/iliac (3)/biomembrane (32) | 98 % | 100 % |
| Â | Nonvascularized and vascularized bone graft | Â | ||||
Muramatsu et al. [20] | 13 | 1.8 [1–4] | Free multiple DS + ICBG | Fibula (8)/femur (4)/scapula (1)/ICBG (8) | 85 % | 100 % |
Tu et al. [17] | 48 | 10.2 [6.5–19] | Free multiple DS + ICBG | Fibular (41)/iliac (4)/Rib (3)/ICBG (48) | 94 % | 100 % |